Publications found:
27
Sort by:
Global AAV Vector Gene Therapy Market Growth 2026-2032
US$ 3,660.00
The global AAV Vector Gene Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. AAV (Adeno-Associated Virus...
May 2026
88 pages
Gene Therapy Market Size, Share, Trends and Forecast by Gene Type, Vector Type, Delivery Method, Application, and Region, 2026-2034
US$ 3,999.00
The global gene therapy market size was valued at USD 6.6 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 19.3 Billion by 2034, exhibiting a CAGR of 12.27% from 2026-20...
March 2026
140 pages
Viral Vectors And Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report By Vector Type (Lentivirus, Adenovirus, Retrovirus), By Workflow, By Application (Gene Therapy, Cell Therapy, Vaccinology), By End-use, By Disease (Cancer, Genetic Disorders), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global viral vector & plasmid DNA manufacturing market size is expected to reach USD 882.9 million by 2025, ... are engaged in strategic mergers & facility acquisitions to meet growing requirements of viral vectors within the pharmaceutical and biotech industries and to broaden their ...
February 2026
120 pages
Gene Therapy CDMO Market Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Drug Development and Manufacturing, Testing and Regulatory Services, and Other Service Types), End User (Pharmaceutical Companies, Biopharmaceutical Companies, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
US$ 4,450.00
The gene therapy CDMO market size is expected to grow from US$ 2.60 billion in 2025 to US$ 14.17 billion by 2034; it is projected to register a CAGR of 20.3% during 2026-2034. The increasing prevalenc...
January 2026
225 pages
Viral Vector Market Size, Share & Trends Analysis Report By Vector Type (AAV, Adenovirus, Lentivirus, Retrovirus), By Application (Cell & Gene Therapy, Vaccine), By End Use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global viral vector market size was estimated at USD 4.25 billion in 2025 and is projected to reach USD 10.22 billion by 2033, growing at a CAGR of 11.69% from 2026 to 2033. The increasing prevale...
January 2026
180 pages
Cell and Gene Therapy Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Cell Therapy and Gene Therapy), Service (Process Development, cGMP Manufacturing, Regulatory Services, and Bioassay Services), Scale (Pre-commercial/R and D Manufacturing and Commercial Scale Manufacturing), Service Providers (CDMOs and CMOs), Transfection Reagents (Polymer-based Transfection Reagents, Lipid-based Transfection Reagents, Viral Transduction Enhancers, and Others), End User (Contract Research Organizations, Pharmaceutical and Biopharmaceutical Companies, and Academic and Research Institutes), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
US$ 4,450.00
The cell and gene therapy market size is expected to grow from US$ 5.30 billion in 2024 to US$ 25.78 billion by 2031; it is projected to register a CAGR of 25.5% during 2025-2031. The increasing preva...
January 2026
300 pages
